DIFFERENTIATION OF HT-29 CELLS - EFFECT ON THE BIOSYNTHESIS AND GLYCOSYLATION OF SUCRASE-ISOMALTASE AND DIPEPTIDYL PEPTIDASE-IV

被引：0

|

作者：

STERCHI, EE ^{[1
]}

NAIM, HY ^{[1
]}

LENTZE, MJ ^{[1
]}

机构：

[1] UNIV BERN,DEPT PAEDIAT GASTROENTEROL,CH-3000 BERN,SWITZERLAND

来源：

PEDIATRIC RESEARCH | 1988年 / 24卷 / 03期

关键词：

D O I：

10.1203/00006450-198809000-00071

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

收藏

页码：413 / 413

页数：1

相关论文

共 12 条

[11] A-BLOOD AND H-BLOOD GROUP ANTIGENS AS MARKERS OF SUCRASE-ISOMALTASE FROM THE ENTEROCYTE-LIKE DIFFERENTIATED HUMAN-COLON CARCINOMA CELL-LINES HT-29 AND CACO-2
CHANTRET, I
CHEVALIER, G
DUSSAULX, E
ZWEIBAUM, A
CANCER RESEARCH, 1987, 47 (05) : 1426 - 1433
[12] Combined treatment with a dipeptidyl peptidase-IV inhibitor (sitagliptin) and an angiotensin II type 1 receptor blocker (losartan) promotes islet regeneration via enhanced differentiation of pancreatic progenitor cells
Liang, J.
Leung, K. K.
Lam, S. Y.
Leung, P. S.
DIABETES OBESITY & METABOLISM, 2012, 14 (09): : 842 - 851